Teva Pharmaceutical Industries Ltd ADR buy Truist Financial Co.
Start price
28.05.25
/
50%
€15.95
Target price
28.05.26
€22.09
Performance (%)
61.13%
Price
15.12.25
€25.70
Summary
This prediction is currently active. With a performance of 61.13% the BUY prediction by Truist_Financial_Co_ is a big success. This prediction currently runs until 28.05.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Teva Pharmaceutical Industries Ltd ADR | 5.328% | 5.328% |
| iShares Core DAX® | 0.795% | 1.458% |
| iShares Nasdaq 100 | -3.088% | -0.762% |
| iShares Nikkei 225® | -0.952% | -2.268% |
| iShares S&P 500 | -1.393% | 0.199% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Teva Pharmaceutical Industries Ltd ADR diskutieren
Teva Pharmaceutical Industries Limited (NYSE: TEVA) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $25.00 price target on the stock.
Ratings data for TEVA provided by MarketBeat